David Vargas Cardenas
- Cancer Research top 5%
- MicroRNA in disease regulation 8
- Hepatology top 5%
- Liver physiology and pathology 3
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment 5
- Hepatitis B Virus Studies 2
- Immunology top 10%
- Molecular Biology top 10%
- Circular RNAs in diseases 6
- Extracellular vesicles in disease 3
-
- Bone and Dental Protein Studies 3
-
- Oral microbiology and periodontitis research 2
- Co-authors
- Tom LueddeChristian TrautweinFrank TackeChristoph RoderburgMihael VucurMark LueddeAlexander KochJérémie Gautheron
- Partner nations
- GermanyAustriaUnited Kingdom
In The Last Decade
David Vargas Cardenas
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 559
- Hepatology 177
- Epidemiology 420
- Immunology 221
- Molecular Biology 700
Countries citing papers authored by David Vargas Cardenas
This map shows the geographic impact of David Vargas Cardenas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Vargas Cardenas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Vargas Cardenas more than expected).
Fields of papers citing papers by David Vargas Cardenas
This network shows the impact of papers produced by David Vargas Cardenas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Vargas Cardenas. The network helps show where David Vargas Cardenas may publish in the future.
Co-authorship network
The 25 scholars most cited alongside David Vargas Cardenas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 5 | |
| 2 | 2019 | 11 | |
| 3 | 2018 | 10 | |
| 4 | 2018 | 3 | |
| 5 | 2015 | 38 | |
| 6 | 2015 | 57 | |
| 7 | 2014 | 111 | |
| 8 | 2014 | 243 | |
| 9 | A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis | 2014 | 24 |
| 10 | 2014 | 104 | |
| 11 | 2013 | 11 | |
| 12 | 2013 | 137 | |
| 13 | 2013 | 103 | |
| 14 | 2013 | 1 | |
| 15 | 2013 | 136 | |
| 16 | 2012 | 104 | |
| 17 | 2012 | 90 | |
| 18 | 2012 | 1 |
About David Vargas Cardenas
David Vargas Cardenas is a scholar working on Cancer Research, Periodontics and Hepatology, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), Circular RNAs in diseases (6 papers), Liver Disease Diagnosis and Treatment (5 papers), Extracellular vesicles in disease (3 papers), Liver physiology and pathology (3 papers), Bone and Dental Protein Studies (3 papers), Oral microbiology and periodontitis research (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Cancer Research (559 citations), Hepatology (177 citations) and Epidemiology (420 citations). David Vargas Cardenas has collaborated with scholars based in Germany, Austria and United Kingdom. Frequent co-authors include Tom Luedde, Christian Trautwein, Frank Tacke, Christoph Roderburg, Mihael Vucur, Mark Luedde, Alexander Koch, Jérémie Gautheron, Norbert Frey and Fabian Benz. Their work appears in journals such as PLoS ONE, Scientific Reports and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.